We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.
- Authors
Takatoku, Masaaki; Uchiyama, Takashi; Okamoto, Shinichiro; Kanakura, Yuzuru; Sawada, Kenichi; Tomonaga, Masao; Nakao, Shinji; Nakahata, Tatsutoshi; Harada, Mine; Murate, Takashi; Ozawa, Keiya
- Abstract
Objective: Myelodysplastic syndromes (MDS) and aplastic anemia (AA) are the most common anemias that require transfusion therapy in Japan. This retrospective survey investigated relationships between iron overload, chelation practices, and morbidity/mortality in patients with these diseases. Method: Medical histories of transfusion-dependent patients were assessed at transfusion onset, chelation onset, and study end. Results: Data were collected from 292 patients with MDS, AA, pure red cell aplasia, myelofibrosis, and other conditions. Patients received a mean of 61.5 red blood cell units during the previous year. Fewer than half (43%) of patients had previously received deferoxamine (DFO) therapy. Only 8.6% received daily/continuous DFO. In all, 75 deaths were reported, with cardiac and liver failure noted in 24.0 and 6.7% of cases. Of these, 97% had ferritin levels >1000 ng/mL. Abnormal cardiac and liver function was observed in 21.9% (14/64) and 84.6% (11/13) of all patients assessed. Effective chelation with DFO resulted in improved serum ferritin, liver enzymes, and fasting blood sugar. Conclusions: Mortality is higher in heavily iron-overloaded patients, with liver and cardiac dysfunction being the primary cause. Daily/continuous chelation therapy was effective at reducing iron burden and improving organ function. Chelation therapy should be initiated once serum ferritin levels exceed 1000 ng/mL.
- Subjects
JAPAN; MYELODYSPLASTIC syndromes; APLASTIC anemia; BLOOD transfusion; ERYTHROCYTES; MYELOFIBROSIS; DEFEROXAMINE; BLOOD sugar
- Publication
European Journal of Haematology, 2007, Vol 78, Issue 6, p487
- ISSN
0902-4441
- Publication type
Article
- DOI
10.1111/j.1600-0609.2007.00842.x